These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 25965188)
21. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Wang XQ; Fan JM; Liu YO; Zhao B; Jia ZR; Zhang Q Int J Pharm; 2011 Oct; 419(1-2):339-46. PubMed ID: 21843612 [TBL] [Abstract][Full Text] [Related]
22. Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with beta-cyclodextrin. Hartell MG; Hicks R; Bhattacharjee AK; Koser BW; Carvalho K; Van Hamont JE J Pharm Sci; 2004 Aug; 93(8):2076-89. PubMed ID: 15236456 [TBL] [Abstract][Full Text] [Related]
23. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Park JH; Choi HK Arch Pharm Res; 2015 Jul; 38(7):1336-44. PubMed ID: 25567762 [TBL] [Abstract][Full Text] [Related]
25. Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology. Steyn JD; Wiesner L; du Plessis LH; Grobler AF; Smith PJ; Chan WC; Haynes RK; Kotzé AF Int J Pharm; 2011 Jul; 414(1-2):260-6. PubMed ID: 21596127 [TBL] [Abstract][Full Text] [Related]
26. Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions. Bando H; McGinity JW Int J Pharm; 2006 Apr; 313(1-2):43-8. PubMed ID: 16487672 [TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery. Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856 [TBL] [Abstract][Full Text] [Related]
28. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion. Bando H; McGinity JW Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652 [TBL] [Abstract][Full Text] [Related]
29. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization of NPC 1161C, a novel antimalarial 8-aminoquinoline, in solution and solid state. Dutta AK; Stodghill SP; Wyandt CM AAPS PharmSciTech; 2011 Mar; 12(1):177-91. PubMed ID: 21191676 [TBL] [Abstract][Full Text] [Related]
32. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Kaur K; Kim K Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342 [TBL] [Abstract][Full Text] [Related]
33. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Akhgari A; Sadeghi F; Garekani HA Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290 [TBL] [Abstract][Full Text] [Related]
34. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Chadha R; Gupta S; Pathak N Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223 [TBL] [Abstract][Full Text] [Related]
35. Sustained-release formulation of sarpogrelate hydrochloride. Kim HJ; Shin DH; Lim EA; Kim JS Arch Pharm Res; 2015 Jan; 38(1):35-41. PubMed ID: 24895147 [TBL] [Abstract][Full Text] [Related]
36. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study. Li S; Pollock-Dove C; Dong LC; Chen J; Creasey AA; Dai WG Mol Pharm; 2012 May; 9(5):1100-8. PubMed ID: 22376012 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of burst release from pH-responsive polymeric microparticles. Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486 [TBL] [Abstract][Full Text] [Related]
38. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release. Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814 [TBL] [Abstract][Full Text] [Related]
39. [Studies on heart-protecting musk pH-dependent gradient-release pellets]. Song HT; Guo T; Zhang RH; Ma Y; Li X; Bi KS Yao Xue Xue Bao; 2002 Oct; 37(10):812-7. PubMed ID: 12567868 [TBL] [Abstract][Full Text] [Related]
40. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex. Piao ZZ; Lee MK; Lee BJ Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]